The grading of lymphovascular space invasion in endometrial carcinoma

Cancer

Volumn 86, Issue 10, 1999, Pages 2090-2097

  Hachisuga, Toru ^a,d   Kaku, Tsunehisa ^b   Fukuda, Kouichi ^c   Eguchi, Fuyuki ^a   Emoto, Makoto ^a   Kamura, Toshiharu ^b   Iwasaka, Tsuyoshi ^c   Kawarabayashi, Tatsuhiko ^a   Sugimori, Hajime ^c   Mori, Mitsuru ^c  

^a FUKUOKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c SAGA UNIVERSITY   (Japan)

^d FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endometrial carcinoma; Lymph node metastasis; Lymphovascular space invasion; Prognosis

Indexed keywords

ARTICLE; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; DIAGNOSTIC VALUE; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; REGRESSION ANALYSIS; SURVIVAL RATE;

EID: 0033570938     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991115)86:10<2090::AID-CNCR29>3.0.CO;2-7     Document Type: Article

References (29)

1. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer 1987;60:2035-41.
2. Homesley HD. Management of endometrial cancer. Am J Obstet Gynecol 1996;174:529-34.
3. Hanson MB, Nagell JRV, Powell DE, Donaldson ES, Gallion H, Merhige M, et al. The prognostic significance of lymphvascular space invasion in stage I endometrial cancer. Cancer 1985;55:1753-7.
4. Gal D, Recio FO, Zamurovic D, Tancer ML. Lymphvascular space involvement - a prognostic indicator in endometrial adenocarcinoma. Gynecol Oncol 1991;42:142-5.
5. Ambros RA, Kurman RJ. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus. Cancer 1992;69:1424-31.
6. Tsuruchi N, Kaku T, Kamura T, Tsukamoto N, Tsuneyoshi M, Akazawa K, et al. The prognostic significance of lymphovascular space invasion in endometrial cancer when conventional hematoxylin and eosin staining is compared to immunohistochemical staining. Gynecol Oncol 1995;57:307-12.
7. Sivridis E, Buckley CH, Fox H. The prognostic significance of lymphatic vascular space invasion in endometrial adenocarcinoma. Br J Obstet Gynecol 1987;94:991-4.
8. Inoue Y, Obata K, Abe K, Ohmura G, Doh K, Yoshioka T, et al. The prognostic significance of vascular invasion by endometrial carcinoma. Cancer 1996;78:1447-51.
9. International Federation of Obstetrics and Gynecology. FIGO stages - 1988 revision. Gynecol Oncol 1989;35:125-6.
10. Zaino RJ, Kurman RJ, Diana KL, Morrow CP. Pathologic models to predict outcome for women with endometrial adenocarcinoma. The importance of the distinction between surgical stage and clinical stage - a Gynecologic Oncology Group study. Cancer 1996;77:1115-21.
11. Nishiya M, Sakuragi N, Hareyama H, Ebina Y, Furuya M, Oikawa M, et al. Cox multivariate regression models for estimating prognosis of patients with endometrioid adenocarcinoma of the uterine corpus who underwent thorough surgical staging. Int J Cancer 1998;79:521-5.
12. Kadar N, Malfetano JH, Homesley HD. Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: implications for therapy. Obstet Gynecol 1992;80:655-9.
13. Hachisuga T, Sugimori H, Kaku T, Tsuneyoshi M. Microcarcinoma of the endometrium: a mapping study with special reference to cytologic atypia in the endometrium. Jpn J Clin Oncol 1992;22:400-5.
14. Hachisuga T, Kawarabayashi T, Iwasaka T, Sugimori H, Kamura T, Tsuneyoshi M. The prognostic value of semiquantitative nuclear grading in endometrial carcinomas. Gyencol Oncol 1997:65;115-20.
15. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ, World Health Organization. Histologicical typing of female genital tract tumours. In: International histologic classification of tumours. 2nd ed. Berlin: Springer-Verlag, 1994: 13-8.
16. Hachisuga T, Sugimori H, Kaku T, Matsukuma K, Tsukamoto N, Nakano H. Glassy cell carcinoma of the endometrium. Gynecol Oncol 1990;36:134-8.
17. Hachisuga T, Kaku T, Enjoji M. Carcinoma of the lower uterine segment. Clinicopathologic analysis of 12 cases. Int J Gynecol Pathol 1989;8:26-35.
18. SAS Institute, Inc. SAS technical report P-200, SAS/STAT software: CALIS and LOGISTIC procedures, release 6.04. Cary, NC, SAS Institute, 1990.
19. Larson DM, Johnson K, Olson KA. Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer: morbidity and mortality. Obstet Gynecol 1992;79:998-1001.
20. Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojin F III, et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995;56:29-33.
21. Onda T, Yoshikawa H, Mizutani K, Mishima M, Yokota H, Nagano H, et al. Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br J Cancer 1997;75:1836-41.
22. Luketich JD, Kassis ES, Shriver SP, Nguyen NT, Schauer PR, Weigel TL, et al. Detection of micrometastases in histologically negative lymph nodes in esophageal cancer. Ann Thorac Surg 1998;66:1715-8.
23. Hayashi N, Arakawa H, Nagase H, Yanagisawa A, Kato Y, Ohta H, et al. Genetic diagnosis identifies occult lymph node metastases undetectable by the histological methods. Cancer Res 1994;54:3853-6.
24. Shivers S, Wang X, Li W, Joseph E, Messina J, Glass F, et al. Molecular staging of malignant melanoma. Correlation with clinical outcome. JAMA 1998;280:1410-5.
25. Podratz K, Mariani A, Webb MJ. Staging and therapeutic value of lymphadenectomy in endometrial cancer. Gynecol Oncol 1998;70:163-4.
26. Silverberg SG, Kurman RJ. Tumors of the uterine corpus and gestational trophoblastic disease. In: Atlas of tumor pathology: third series, fascicle 3. Washington, DC: Armed Forces Institute of Pathology, 1992:65.
27. Carcangiu ML, Chambers JT. Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival. Int J Gynecol Pathol 1995;14:30-8.
28. Yura Y, Tauchi K, Koshiyama M, Konishi I, Yura S, Mori T, et al. Parametrial involvement in endometrial carcinomas: its incidence and correlation with other histological parameters. Gynecol Oncol 1996;63:114-9.
29. Lanciano RM, Greven KM. Adjuvant treatment for endometrial cancer: who needs it? Gynecol Oncol 1995;57:135-7.